86 Infos zu Khalid Shoumariyeh

Mehr erfahren über Khalid Shoumariyeh

Lebt in

Infos zu

3 Aktuelle Nachrichten

COVID Vaccine Shields People with Blood CancerMirage News

— Andrea Keppler-Hafkemeyer, Christine Greil, Paul R. Wratil, Khalid Shoumariyeh, Marcel Stern, Annika Hafkemeyer, Driti Ashok, ...

HybridveranstaltungSchwarzwald-Baar Klinikum

— Dr. Khalid Shoumariyeh Uhr. Diskussion: Dr. Gabriele Käfer Uhr. Akute Leukämien, Zelltherapie. Prof. Dr. Jürgen Finke.

Mast cell deficiency prevents BCR::ABL1 induced ...X-MOL

— ... Khalid Shoumariyeh 7, 13, 15 , Michael Huber 5 , Mirle Schemionek-Reinders 3, 4 , Tilman Brummer 1, 13, 15, 16 , Sebastian Halbach 1, 13.

6 Profile in Sozialen Netzwerken

LinkedIn: Khalid Shoumariyeh | Berufsprofil - LinkedIn

Sehen Sie sich Khalid Shoumariyehs vollständiges Profil an. Es ist kostenlos. Ihre Kollegen, Kommilitonen und 500 Millionen weitere Fach- und Führungskräfte ... Es fehlt: twistetal

LinkedIn: Khalid Shoumariyeh | LinkedIn

Sehen Sie sich das berufliche Profil von Khalid Shoumariyeh (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach

pinterest.com: Khalid Shoumariyeh

0 Pins • 0 Followers

Khalid Shoumariyeh, Arzt at Uniklinikum FreiburgData-lead.com

Arzt (Physician) at Uniklinikum Freiburg. See Khalid Shoumariyeh's contact information such as email address, phone number and linkedin page.

3 Hobbys & Interessen

Dissecting the role of the ubiquitin proteasome system in the ...CORDIS

... Michele C Buck, Khalid Shoumariyeh, Philipp Moog, Juliana Schwaab, Andreas Reiter, Knut Brockow, Katharina Götze, Florian Bassermann, Ulrike Höckendorf, ...

International prognostic scoring system for mastocytosis (IPSM)

... Patrizia Bonadonna, MD, Massimiliano Bonifacio, MD, Cecelia Perkins, MPH, Anja Illerhaus, PhD, Chiara Elena, MD, Serena Merante, MD, Khalid Shoumariyeh, María Jara-Acevedo, PhD, Roberta Zanotti, MD, Cecelia Perkins, MPH, Mohamad Jawhar, MD, Wolfgang R Sperr, MD, Khalid Shoumariyeh, MD, Juliana Schwaab, ... › lanhae › article › ppt

COVID-19: Impfung schützt auch Menschen mit BlutkrebsInformationsdienst Wissenschaft

— Andrea Keppler-Hafkemeyer, Christine Greil, Paul R. Wratil, Khalid Shoumariyeh, Marcel Stern, Annika Hafkemeyer, Driti Ashok, ...

1 Firmen-Mitarbeiter

Publications Vito SabatoUniversiteit Antwerpen

... Roberta Zanotti, Massimiliano Bonifacio, Patrizia Bonadonna, Khalid Shoumariyeh, Nikolas von Bubnoff, Sabine Mueller, Cecelia Perkins, Chiara Elena, ...

9 Bücher zum Namen

Demethylating therapy increases anti-CD123 CAR T cell ...Directory of Open Access Journals

... Konrad Aumann,; Jade Clarson,; Janaki Manoja Vinnakota,; Khalid Shoumariyeh,; Cornelius Miething,; Angel F. Lopez,; Michael P. Brown,; Justus Duyster, ...

Khalid Shoumariyeh - ResearchPadresearchpad.co

Khalid Shoumariyeh, Johannes Jung, Michael Rassner, Sandra Maria Dold, Veronika Riebl, Milena Pantic, Georg Herget, Reinhard Marks, Michael Lübbert, ...

Das Blaue Buch: Chemotherapie-Manual Hämatologie und Onkologiegoogle.ca

... Giulia Graziani, Theresa Lowinus, Alexander Keller, Stefanie Kreutmair, Lynn Leppla, Khalid Shoumariyeh und Markus Ruch. Bei der Arbeit mit der 7.

Clinical Characteristics and Outcome of Multiple Myeloma Patients ...

Monika Engelhardt, Khalid Shoumariyeh, Amelie Rösner, Gabriele Ihorst, Francesca Biavasco, Katharina Elisabeth Meckel, Ivana von Metzler, Sebastian Treurich ... › about

7 Dokumente

TheranosticsDiVA portal

von PS Freiburg · · Zitiert von: 24 — Khalid Shoumariyeh: travel support from. Abbvie and consultancy fees from Novartis. Nikolas von Bubnoff: institutional financial.

Clinical characteristics and outcome of multiple myeloma ...ScienceOpen

Author(s): Monika Engelhardt Khalid Shoumariyeh Amelie Rösner , Gabriele Ihorst , Francesca Biavasco Katharina Meckel , Ivana von Metzler ...

Covid‐19 in patients with hematological and solid cancers ...ProQuest

von K Shoumariyeh · · Zitiert von: 36 — Khalid Shoumariyeh, Francesca Biavasco, Monika Engelhardt, and Hartmut Bertz contributed equally. 1Department of Medicine I, Medical. Center

Mast cell leukemia: clinical and molecular features and ...ashpublications.org

von VE Kennedy · · Zitiert von: 11 — Khalid Shoumariyeh,. Khalid Shoumariyeh. 14Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, ...

7 Wissenschaftliche Publikationen

Targeting MDM2 enhances antileukemia immunity after ...ScienceDirect

von JNHG Ho · · Zitiert von: 10 — Felicitas Koppers 1 , Khalid Shoumariyeh 1 6 , Helena Engel 1 … Robert Zeiser Show more. Add to Mendeley. Share. Cite.

Metabolic reprogramming of donor T cells enhances graft ...Science

von FM Uhl · · Zitiert von: 64 — Jörg Büscher, Sandra Duquesne, Wolfgang Melchinger, Barbara Sauer, Khalid Shoumariyeh https://orcid.org , Annette Schmitt-Graeff ...

Patient-derived xenograft mouse models to investigate ...Universität zu Lübeck

von LK Isbell · · Zitiert von: 1 — Lisa Kristina Isbell, Cordula Tschuch, Soroush Doostkam, Silvia Waldeck, Geoffroy Andrieux, Khalid Shoumariyeh, Dorothee Lenhard, Hans Eckart Schaefer, ...

Rigorosa - Medizinische Fakultät

Herr Khalid Shoumariyeh , 15:00 Uhr, ITZ-Ambulanz, Prüfer: Prof. Dr. Wäsch, Beisitz: Dr. Isbell, Fach: Innere Medizin , 15:00 Uhr, ... › promotionen › rigor...

2 Allgemeine Veröffentlichungen

Oncogenic KrasG12D causes myeloproliferation via EconPapers

... Janaki Manoja Vinnakota, Martina Konantz, Franziska M. Uhl, Heiko Becker, Michael Lübbert, Khalid Shoumariyeh, Christoph Schürch, Geoffroy Andrieux, ... › ReP...

Comprehensive characterization of central BCL-2 family ...

von TO Odinius · · Zitiert von: 3 — Khalid Shoumariyeh. German Cancer Consortium (DKTK) Partner Site Freiburg, Freiburg im Breisgau, Germany. Khalid Shoumariyeh. › article

2 Meinungen & Artikel

Demethylating therapy increases anti-CD123 CAR T Nature

von N El Kha…y · · Zitiert von: 17 — Nadia El Kha…y, Sanaz Taromi, Janaki Manoja Vinnakota, Khalid Shoumariyeh, Cornelius Miething, Justus Duyster & Robert Zeiser. › articles

Mast cell deficiency prevents BCR::ABL1 induced ...Nature Journal

von M Langhammer · — Robert Zeiser, Heiko Becker, Khalid Shoumariyeh, Tilman Brummer & Sebastian Halbach. Department of Pathology, University Hospital, ...

42 Webfunde aus dem Netz

Amina Lazrak - Software Engineer II - Precision Care - Colorlinkedin.com

Khalid Shoumariyeh. MD at University Hospital Freiburg. Clinician and Scientist. Research focus on tumor immunology, chromatin regulation & myeloid ... Los Angeles, California, United States · Software Engineer II - Precision Care · ColorKhalid Shoumariyeh. MD at University Hospital Freiburg. Clinician and Scientist. Research focus on tumor immunology, chromatin regulation & myeloid ...

Jianquan W. – Global Digital Marketing Intern – Henkellinkedin.com

Khalid Shoumariyeh. MD at University Hospital Freiburg. Clinician and Scientist. Research focus on tumor immunology, chromatin regulation & myeloid ... Khalid Shoumariyeh. MD at University Hospital Freiburg. Clinician and Scientist. Research focus on tumor immunology, chromatin regulation & myeloid ...

Jurik Mutter - Forscher (Postdoktorand) - Stanford Universitylinkedin.com

Khalid Shoumariyeh. MD at University Hospital Freiburg. Clinician and Scientist. Research focus on tumor immunology, chromatin regulation & myeloid ... United States · Forscher (Postdoktorand) · Stanford UniversityKhalid Shoumariyeh. MD at University Hospital Freiburg. Clinician and Scientist. Research focus on tumor immunology, chromatin regulation & myeloid ...

Khalid Shoumariyeh, MD, MScGoogle Scholar

Khalid Shoumariyeh, MD, MSc. University Hospital Freiburg. Bestätigte E-Mail-Adresse bei uniklinik-freiburg.de. Tumor ImmunologyT Cell DevelopmentChromatin ...

A novel conditional NPM-ALK-driven model of CD30+ T- ...Gale Cengage

von K Shoumariyeh · · Zitiert von: 6 — A novel conditional NPM-ALK-driven model of CD30+ T-cell lymphoma mediated by a translational stop cassette. Citation metadata. Authors: Khalid Shoumariyeh, ...

ART. 3.pdf.txtUniversidad de Salamanca

... MD15, Khalid Shoumariyeh, MD13, Juliana Schwaab, MD12, Georg Greiner, MD18, Ana Henriques, PhD2,3, Carolina Caldas, MSc1,2, Carlos Fernández-Giménez, ...

Analysis of survival by tumor response - OUCI

von G Ihorst · · Zitiert von: 4 — Monika Engelhardt, Gabriele Ihorst, Martin Schumacher, Michael Rassner, Laura Gengenbach, Mandy Möller, Khalid Shoumariyeh, Jakob Neubauer, ... › works

Clinical features and survival of patients with indolent ...Read by QxMD

... Anna B Fortina, Khalid Shoumariyeh, Mohamad Jawhar, Roberta Zanotti, Patrizia Bonadonna, Francesca Caroppo, Alexander Zink, Massimo Triggiani, ...

Articles Prognostication Score for Systemic Mastocytosis

von JI Muñoz González · — Perkins MPH11, Mohamad Jawhar, MD12, Wolfgang R. Sperr, MD15, Khalid Shoumariyeh, MD13, Juliana Schwaab, MD12,Georg. Greiner, MD18, Ana Henriques, PhD2,3, ... › bitstream

Demethylating therapy increases anti-CD123 CAR T cell ...Handle Proxy

... Janaki Manoja Vinnakota (University of Freiburg) ; Khalid Shoumariyeh (University of Freiburg) ; Cornelius Miething (University of Freiburg) ; Angel F ...

Demethylating therapy increases anti Library Catalogue

... Janaki Manoja Vinnakota (University of Freiburg) ; Khalid Shoumariyeh (University of Freiburg) ; Cornelius Miething (University of Freiburg) ; Angel F ... › f...

Friday, September 16ECNM 2022

Khalid Shoumariyeh (Freiburg, Germany). 11:35 Impact of CD2, CD25 and CD30 Expression on MC in SM (PR36) Axel Rüfer (Luzern, Switzerland).

Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity ...

... Wenbo Yu, Renier Myburgh, Tony Matschulla, Sanaz Taromi, Konrad Aumann, Jade Clarson, Janaki Manoja Vinnakota, Khalid Shoumariyeh, Cornelius Miething, ... › ...

Elevated RIPK3 …lates with disease burden in myelofibrosis

vor 2 Tagen — Veronika Dill, Celina Victoria Wagner, Eva C. Keller, Francisco Jose Fernandez-Hernandez, Khalid Shoumariyeh, Timo O. Odinius, ... › doi

MARS: Mutation-Adjusted Risk Score for Advanced ...ASCO Journals

von M Jawhar · · Zitiert von: 96 — Khalid Shoumariyeh, MD4. x. Khalid Shoumariyeh. Search for articles by this author. ; Nicole Naumann, PhD1. x. Nicole Naumann.

Journal of Allergy and Clinical Immunology – In Practice

... Khalid Shoumariyeh, Nikolas von Bubnoff, Sabine Müller, Cecelia Perkins, Chiara Elena, Luca Malcovati, Hans Hagglund, Mattias Mattsson, Roberta Parente, ... › ...

Long-term safety and efficacy of dasatinib in the treatment of ...

von K Shoumariyeh · · Zitiert von: 2 — Authors: Khalid Shoumariyeh and Nikolas von Bubnoff. Date: Annual From: Blood and Lymphatic Cancer: Targets and Therapy(Vol. 4). › i.do

MARS: Mutation-Adjusted Risk Score for Advanced Systemic ...

Journal of Clinical Oncology, November · jco · · Mohamad Jawhar, Juliana Schwaab, Iván Álvarez-Twose, Khalid Shoumariyeh, Nicole ... › details

Ohne Titeleds-design.com

Dr. Khalid Shoumariyeh ... Dr. Shoumariyeh Muhsen in Wien : Arztsuche24.at Orvos a közelben Dr Shoumariyeh Muhsen - at.near-place.com ...

Oncogenic Kras G12D causes myeloproliferation via ...Europe PMC

von S Hamarsheh · · Zitiert von: 91 — ... Michael Lübbert,1Khalid Shoumariyeh,1 Christoph Schürch,5 Geoffroy Andrieux,6 Nils Venhoff,7 Annette Schmitt-Graeff,8 Sandra Duquesne,1 Dietmar Pfeifer ...

Bedeutung zum Vornamen Khalid

Männlicher Vorname (Arabisch): Khalid; ewig;; khalid = ewig

Verwandte Personensuchen

Personensuche zu Khalid Shoumariyeh & mehr

Die Personensuchmaschine Namenfinden.de ist die neue Personensuche für Deutschland, die Profile, Kontaktdaten, Bilder, Dokumente und Webseiten zu Khalid Shoumariyeh und vielen weiteren Namen aus öffentlich zugänglichen Quellen im Internet anzeigt.